MS-DRG v44.0 · MDC 18: Infectious and Parasitic Diseases, Systemic or Unspecified Sites
865 — Viral Illness with MCC
- Relative weight
- 1.3485
- Geometric mean LOS
- 3.7 days
- Arithmetic mean LOS
- 5.1 days
- Type
- Medical
About MS-DRG 865
MS-DRG 865, Viral Illness with MCC, is a medical DRG in MDC 18 (Infectious and Parasitic Diseases, Systemic or Unspecified Sites) under MS-DRG version 44.0, which applies to inpatient discharges from October 1, 2026 through September 30, 2027.
Its FY2027 relative weight is 1.3485, so Medicare's base payment for this DRG is about 1.35 times the average inpatient case, before hospital-specific adjustments. The geometric mean length of stay is 3.7 days and the arithmetic mean is 5.1 days.
It belongs to a 2-level severity family: DRG 865 (with MCC, weight 1.3485) and DRG 866 (without MCC, weight 0.8692). The highest-severity level carries 1.6 times the weight of the lowest, which is why documenting CC and MCC conditions matters.
141 ICD-10-CM diagnosis codes are part of this DRG's grouping logic; they are listed below.
ICD-10-CM codes that group to DRG 865 (141)
Chapter 1: Certain infectious and parasitic diseases
- A70Chlamydia psittaci infections
- A74.81Chlamydial peritonitis
- A74.89Other chlamydial diseases
- A74.9Chlamydial infection, unspecified
- A80.4Acute nonparalytic poliomyelitis
- A90Dengue fever [classical dengue]
- A91Dengue hemorrhagic fever
- A92.0Chikungunya virus disease
- A92.1O'nyong-nyong fever
- A92.30West Nile virus infection, unspecified
- A92.31West Nile virus infection with encephalitis
- A92.32West Nile virus infection with other neurologic manifestation
- A92.39West Nile virus infection with other complications
- A92.4Rift Valley fever
- A92.5Zika virus disease
- A92.8Other specified mosquito-borne viral fevers
- A92.9Mosquito-borne viral fever, unspecified
- A93.0Oropouche virus disease
- A93.1Sandfly fever
- A93.2Colorado tick fever
- A93.8Other specified arthropod-borne viral fevers
- A94Unspecified arthropod-borne viral fever
- A95.0Sylvatic yellow fever
- A95.1Urban yellow fever
- A95.9Yellow fever, unspecified
- A96.0Junin hemorrhagic fever
- A96.1Machupo hemorrhagic fever
- A96.2Lassa fever
- A96.8Other arenaviral hemorrhagic fevers
- A96.9Arenaviral hemorrhagic fever, unspecified
- A98.0Crimean-Congo hemorrhagic fever
- A98.1Omsk hemorrhagic fever
- A98.2Kyasanur Forest disease
- A98.3Marburg virus disease
- A98.4Ebola virus disease
- A98.8Other specified viral hemorrhagic fevers
- A99Unspecified viral hemorrhagic fever
- B00.89Other herpesviral infection
- B01.0Varicella meningitis
- B01.81Varicella keratitis
- B01.89Other varicella complications
- B01.9Varicella without complication
- B02.7Disseminated zoster
- B02.8Zoster with other complications
- B03Smallpox
- B04Monkeypox
- B05.1Measles complicated by meningitis
- B05.4Measles with intestinal complications
- B05.89Other measles complications
- B05.9Measles without complication
- B06.81Rubella pneumonia
- B06.89Other rubella complications
- B06.9Rubella without complication
- B08.010Cowpox
- B08.011Vaccinia not from vaccine
- B08.04Paravaccinia, unspecified
- B08.09Other orthopoxvirus infections
- B08.20Exanthema subitum [sixth disease], unspecified
- B08.21Exanthema subitum [sixth disease] due to human herpesvirus 6
- B08.22Exanthema subitum [sixth disease] due to human herpesvirus 7
- B08.3Erythema infectiosum [fifth disease]
- B08.4Enteroviral vesicular stomatitis with exanthem
- B08.60Parapoxvirus infection, unspecified
- B08.61Bovine stomatitis
- B08.62Sealpox
- B08.69Other parapoxvirus infections
- B08.70Yatapoxvirus infection, unspecified
- B08.71Tanapox virus disease
- B08.72Yaba pox virus disease
- B08.79Other yatapoxvirus infections
- B08.8Other specified viral infections characterized by skin and mucous membrane lesions
- B09Unspecified viral infection characterized by skin and mucous membrane lesions
- B25.8Other cytomegaloviral diseases
- B25.9Cytomegaloviral disease, unspecified
- B26.82Mumps myocarditis
- B26.83Mumps nephritis
- B26.85Mumps arthritis
- B26.89Other mumps complications
- B26.9Mumps without complication
- B27.00Gammaherpesviral mononucleosis without complication
- B27.01Gammaherpesviral mononucleosis with polyneuropathy
- B27.02Gammaherpesviral mononucleosis with meningitis
- B27.09Gammaherpesviral mononucleosis with other complications
- B27.10Cytomegaloviral mononucleosis without complications
- B27.11Cytomegaloviral mononucleosis with polyneuropathy
- B27.12Cytomegaloviral mononucleosis with meningitis
- B27.19Cytomegaloviral mononucleosis with other complication
- B27.80Other infectious mononucleosis without complication
- B27.81Other infectious mononucleosis with polyneuropathy
- B27.82Other infectious mononucleosis with meningitis
- B27.89Other infectious mononucleosis with other complication
- B27.90Infectious mononucleosis, unspecified without complication
- B27.91Infectious mononucleosis, unspecified with polyneuropathy
- B27.92Infectious mononucleosis, unspecified with meningitis
- B27.99Infectious mononucleosis, unspecified with other complication
- B33.1Ross River disease
- B33.3Retrovirus infections, not elsewhere classified
- B33.4Hantavirus (cardio)-pulmonary syndrome [HPS] [HCPS]
- B33.8Other specified viral diseases
- B34.0Adenovirus infection, unspecified
- B34.1Enterovirus infection, unspecified
- B34.2Coronavirus infection, unspecified
- B34.3Parvovirus infection, unspecified
- B34.4Papovavirus infection, unspecified
- B34.8Other viral infections of unspecified site
- B34.9Viral infection, unspecified
- B97.0Adenovirus as the cause of diseases classified elsewhere
- B97.10Unspecified enterovirus as the cause of diseases classified elsewhere
- B97.11Coxsackievirus as the cause of diseases classified elsewhere
- B97.12Echovirus as the cause of diseases classified elsewhere
- B97.19Other enterovirus as the cause of diseases classified elsewhere
- B97.21SARS-associated coronavirus as the cause of diseases classified elsewhere
- B97.29Other coronavirus as the cause of diseases classified elsewhere
- B97.30Unspecified retrovirus as the cause of diseases classified elsewhere
- B97.31Lentivirus as the cause of diseases classified elsewhere
- B97.32Oncovirus as the cause of diseases classified elsewhere
- B97.33Human T-cell lymphotrophic virus, type I [HTLV-I] as the cause of diseases classified elsewhere
- B97.34Human T-cell lymphotrophic virus, type II [HTLV-II] as the cause of diseases classified elsewhere
- B97.35Human immunodeficiency virus, type 2 [HIV 2] as the cause of diseases classified elsewhere
- B97.39Other retrovirus as the cause of diseases classified elsewhere
- B97.4Respiratory syncytial virus as the cause of diseases classified elsewhere
- B97.5Reovirus as the cause of diseases classified elsewhere
- B97.6Parvovirus as the cause of diseases classified elsewhere
- B97.7Papillomavirus as the cause of diseases classified elsewhere
- B97.81Human metapneumovirus as the cause of diseases classified elsewhere
- B97.89Other viral agents as the cause of diseases classified elsewhere
Chapter 10: Diseases of the respiratory system
- J09.X3Influenza due to identified novel influenza A virus with gastrointestinal manifestations
- J09.X9Influenza due to identified novel influenza A virus with other manifestations
- J10.2Influenza due to other identified influenza virus with gastrointestinal manifestations
- J10.81Influenza due to other identified influenza virus with encephalopathy
- J10.82Influenza due to other identified influenza virus with myocarditis
- J10.83Influenza due to other identified influenza virus with otitis media
- J10.89Influenza due to other identified influenza virus with other manifestations
- J11.2Influenza due to unidentified influenza virus with gastrointestinal manifestations
- J11.81Influenza due to unidentified influenza virus with encephalopathy
- J11.82Influenza due to unidentified influenza virus with myocarditis
- J11.83Influenza due to unidentified influenza virus with otitis media
- J11.89Influenza due to unidentified influenza virus with other manifestations
Chapter 12: Diseases of the skin and subcutaneous tissue
Chapter 19: Injury, poisoning and certain other consequences of external causes
Chapter 21: Factors influencing health status and contact with health services
Common questions about DRG 865
What is the relative weight of DRG 865?
- 1.3485 for FY2027 (MS-DRG v44.0), from the IPPS final rule Table 5.
What is the average length of stay for DRG 865?
- The geometric mean length of stay is 3.7 days; the arithmetic mean is 5.1 days.
Is DRG 865 medical or surgical?
- DRG 865 is a medical DRG.